Vallejo-Vaz, Antonio J.
Bray, Sarah
Villa, Guillermo
Brandts, Julia
Kiru, Gaia
Murphy, Jennifer
Banach, Maciej
De Servi, Stefano
Gaita, Dan
Gouni-Berthold, Ioanna
Kees Hovingh, G.
Jozwiak, Jacek J.
Jukema, J. Wouter
Gabor Kiss, Robert
Kownator, Serge
Iversen, Helle K.
Maher, Vincent
Masana, Luis
Parkhomenko, Alexander
Peeters, André
Clifford, Piers
Raslova, Katarina
Siostrzonek, Peter
Romeo, Stefano
Tousoulis, Dimitrios
Vlachopoulos, Charalambos
Vrablik, Michal
Catapano, Alberico L.
Poulter, Neil R.
Ray, Kausik K. http://orcid.org/0000-0003-0508-0954
,
Funding for this research was provided by:
Amgen
Article History
Accepted: 27 April 2022
First Online: 14 May 2022
Declarations
:
: AJV-V acknowledges past or current participation in research grants to Imperial College London from Pfizer, Amgen, MSD, Sanofi-Aventis, Daiichi Sankyo, and Regeneron; and received personal fees for consulting from Bayer and Regeneron and honoraria for lectures from Amgen, Mylan, and Akcea; all outside the submitted work.SB is an employee of Amgen Ltd and holds stock in Amgen.GV is an employee of Amgen (Europe) GmbH and holds stock in Amgen.JB has received speaker honoraria from Amgen and research grant support from AstraZeneca.GK has no relevant disclosures.JM has no relevant disclosures.MB has participated in speakers bureau for Akcea, Amgen, Daiichi Sankyo, KRKA, MSD, Mylan, Polpharma, Sanofi-Aventis, Servier, and Valeant; served as a consultant to Abbott Vascular, Akcea, Amgen, Daiichi Sankyo, Esperion, Freia Pharmaceuticals, MSD, Polfarmex, Resverlogix, and Sanofi-Aventis; and received grants from Mylan, Sanofi, and Valeant.SDS has no relevant disclosures.DG has received honoraria for educational activities from Amgen, AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Merck, Mylan, Novartis, Novo Nordisk, Pfizer, Sanofi, and Servier.IG-B has received personal fees and non-financial support from Akcea, Amgen and Sanofi, and personal fees from Aegerion, Amarin, Daiichi Sankyo, Novartis, and Regeneron, outside the submitted work.GKH has received funding for clinical trial activities and/or lecture fees from Aegerion, Amgen, AstraZeneca, Eli Lilly, Genzyme, Kowa, Pfizer, Regeneron Pharmaceuticals, Roche, Sanofi, The Medicines Company, and Ionis until April 2019, and fees were paid to his institute. Since April 2019 GKH is part-time employed by Novo Nordisk.JJJ has received research grant/support from Valeant, and has served as a consultant or speaker for ALAB Laboratories, Amgen, Bioton, Boehringer Ingelheim, Celgene, Microlife, Servier, Teva, and Valeant.JWJ or his institution department has received research grants from, and/or was a speaker (with or without lecture fees) at meetings sponsored by Amgen, AstraZeneca, Athera, Biotronik, Boston Scientific, Dalcor, Daiichi Sankyo, Lilly, Medtronic, Merck-Schering-Plough, Pfizer, Roche, Sanofi-Aventis, The Medicine Company, the Netherlands Heart Foundation, CardioVascular Research the Netherlands (CVON), the Netherlands Heart Institute and the European Community Framework KP7 Programme.RGK has received honoraria from, and has been a member of the speakers bureau for, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Merck, Pfizer, and Sanofi-Aventis.SK has received grant/research support from Amgen, AstraZeneca, and Bayer; and consulting fees/honoraria from Amgen, Bayer, BMS, Boehringer Ingelheim, MSD, Mesi, Pfizer, Philips Healthcare, Sanofi, and Servier.HKI has received honoraria for contributing to advisory boards or oral presentations from Allergan, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, MSD, Pfizer, and St Jude.VM has no conflict of interest relevant to this publication.LM has received fees for lectures and/or advisory work from Amarin, Amgen, Amryt, Mylan, Novartis, Sanofi-Regeneron, and Servier. APa has received research grants and personal fees from Amgen, AstraZeneca, Bayer, Pfizer, and Sanofi-Aventis. APe has no relevant disclosures.PC has no relevant disclosures.KR has received research grants for clinical trials, and consulting fees and honoraria for presentations, from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Gilead, Merck, Mylan, Novo Nordisk, Pfizer, Sanofi, and Zentiva.PS has received honoraria for being a speaker and advisory board member from Amgen, AstraZeneca, MSD, and Sanofi.SR has received honoraria for being a speaker and advisory board member from Akcea, Amgen, AstraZeneca, and Sanofi; and grants from Amgen, AstraZeneca, and Sanofi.DT has no relevant disclosures.CV has received research grant(s)/support and honoraria from Amgen, ELPEN, MSD, Sanofi, and VIANEX.MV has received grants, personal fees, or non-financial support from Abbott Laboratories, Amgen, AstraZeneca, Boehringer Ingelheim, KRKA, Mylan, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, Servier, and Zentiva, outside of the submitted work.ALC has received research grant(s)/support from Amgen, Eli Lilly, Mylan, Menarini, Sanofi, and Sanofi-Regeneron; and has served as a consultant for or received honoraria from Aegerion, Akcea, Amgen, Amryt, AstraZeneca, Daiichi Sankyo, Esperion, Genzyme, Ionis Pharmaceuticals, Kowa, Medco, Menarini, MSD, Mylan, Novartis, Recordati, Regeneron, and Sanofi.NRP has received financial support from several pharmaceutical companies that manufacture lipid-lowering agents, for consultancy fees (Amgen and Pfizer), research projects and staff (Amgen and Pfizer), and for arranging and speaking at educational meetings (Amgen, MSD, and Pfizer). He holds no stocks and shares in any such companies. NRP is supported by the National Institute for Health Research Senior Investigator Awards, Biomedical Research Centre funding, and the British Heart Foundation Research Centre Excellence Award.KKR reports grants from Amgen during the conduct of the study; and has received personal fees from AbbVie, Aegerion, Akcea, Algorithm, AstraZeneca, Bayer, Boehringer Ingelheim, Cerenis, Cipla, Dr Reddys, Esperion, Kowa, Lilly, Novartis, Silence Therapeutics, Takeda, The Medicines Company, and Zuellig Pharma; and grants and personal fees from Amgen, Daiichi Sankyo, MSD, Sanofi-Regeneron, and Pfizer, outside the submitted work.